Purchase femto pulse automated pulsed-field electrophoresis system with installation, and training plus four one year optional preventive maintenance services

Ended Purchase Order Awarded Last action

Contract number
75F40119P10091
Awardee
Awarding agency
Obligated
$107,945

Award facts

Contract value 91% obligated
  • $107,945.17 Current, with exercised options
  • $118,937.17 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Marshallton, DE 19808, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$10,992
Other Administrative Action P00006 $0
Exercise an Option P00005 $10,992
Other Administrative Action P00004 · COR change from tahira reeves to robin wilson $0
Exercise an Option P00003 $10,992
Other Administrative Action P00002 · Administrative modification to correct the option years dates for preventive maintenance agreement - crosslab silver femto pulse system $0
Exercise an Option P00001 · Modification exercising option year one for preventive maintenance agreement - crosslab silver femto pulse system $10,992
Original award $85,961

About this award

Agilent Technologies Inc. was awarded a firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration on February 25, 2019 for $118,937.17 to purchase a Femto Pulse Automated Pulsed-Field Electrophoresis System with installation, training, and four optional one-year preventive maintenance services. The system will support the FDA's research and testing activities. No set-aside designation was used for this procurement. Agilent Technologies Inc. is a subsidiary of Agilent Technologies, Inc., a global leader in life sciences and diagnostics that provides analytical laboratory equipment and services to various government agencies. The award was made in response to a February 5, 2019 solicitation with a February 14 due date for an automated pulsed-field capillary electrophoresis instrument and associated preventive maintenance agreement and training.

Quick answers

Who was awarded contract 75F40119P10091?

75F40119P10091 was awarded to Agilent Technologies Inc. by Food and Drug Administration (Department of Health and Human Services) on February 25, 2019.

How much is contract 75F40119P10091 worth?

The government has obligated $107,945 on 75F40119P10091. Its potential value, with all options, is $118,937.

Was contract 75F40119P10091 competed?

The extent of competition for 75F40119P10091 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award